Acute Lymphoblastic Leukemia Panel

15,000.00

The Acute Lymphoblastic Leukemia Panel is a group of diagnostic tests used to detect and classify Acute Lymphoblastic Leukemia (ALL), a fast-growing cancer of the lymphoid line of blood cells. This panel often includes a complete blood count (CBC) with differential, peripheral blood smear, bone marrow aspiration and biopsy, immunophenotyping (flow cytometry), cytogenetic analysis, and molecular genetic testing. These tests help identify abnormal lymphoblasts and specific genetic changes associated with ALL.

Enquiry Here

    Description

    Why It’s Done:

    • To diagnose Acute Lymphoblastic Leukemia in patients showing symptoms like fatigue, frequent infections, bleeding, or bone pain.
    • To determine the exact subtype of ALL for tailored treatment planning.
    • To detect genetic abnormalities that affect prognosis and guide targeted therapy.
    • To monitor treatment effectiveness and detect relapse.
    • To assist in risk stratification and treatment decisions.

    Preparation:

    • Blood tests usually require no special preparation; fasting is generally not needed.
    • Bone marrow aspiration and biopsy may require fasting for several hours and avoidance of certain medications, as advised by the healthcare provider.
    • Inform your doctor about any current medications, allergies, or health conditions before the test.
    • Follow any additional instructions provided by your healthcare team regarding the procedure